University of Lynchburg DMSc Doctoral Project Assignment Repository
Specialty
Autoinflammatory and Autoimmune Disease
Advisor
Professor Thomas Colletti, DHSc, MPAS, PA-C
Abstract
ABSTRACT
The purpose of this article is to review the potential impact of anti-drug antibody (ADA) development on the safety and efficacy of biotherapeutics when treating autoinflammatory and autoimmune diseases. Awareness of ADAs can assist providers in making treatment decisions in their autoimmune and autoinflammatory patients, such as biotherapeutic drug or class switch.
Recommended Citation
Menefee EK. The Impact of Anti-Drug Antibody Development on the Efficacy and Safety of Biotherapeutics for the Treatment of Autoinflammatory and Autoimmune Disease States. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2021; 4(1).
Restricted
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.